Related Experiment Video
Updated: Jul 15, 2026

Affinity Purification of Influenza Virus Ribonucleoprotein Complexes from the Chromatin of Infected Cells
Published on: June 3, 2012
Peptide-mediated interference with influenza A virus polymerase.
Alexander Ghanem1, Daniel Mayer, Geoffrey Chase
1Department of Virology, Institute for Medical Microbiology and Hygiene, University of Freiburg, Hermann-Herder-Strasse 11, D-79104 Freiburg, Germany.
Targeting influenza A virus polymerase subunit interactions with specific peptides inhibits viral replication. A peptide blocking PB1 binding to PA disrupts polymerase complex assembly and viral spread, offering a novel antiviral strategy.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- Influenza A virus RNA synthesis relies on the assembly of its polymerase complex, comprising subunits PB1, PB2, and PA.
- Understanding protein-protein interactions within the polymerase complex is crucial for developing antiviral therapies.
Purpose of the Study:
- To investigate whether targeting protein-protein interaction domains of influenza A virus polymerase subunits can inhibit viral replication.
- To evaluate the efficacy of specific peptides in disrupting polymerase complex assembly and viral spread.
Main Methods:
- Designed and synthesized peptides targeting specific protein-protein interaction domains within the PB1, PB2, and PA subunits.
- Assessed the impact of these peptides on polymerase complex formation in vitro.
- Measured viral replication and spread in the presence of inhibitory peptides.
Main Results:
- Peptides binding to protein-protein interaction domains of polymerase subunits interfered with complex assembly.
- A 25-amino-acid peptide corresponding to the PA-binding domain of PB1 significantly blocked influenza A virus polymerase activity.
- This peptide effectively inhibited viral replication and spread.
Conclusions:
- Disrupting polymerase subunit interactions is a viable strategy for inhibiting influenza A virus replication.
- Targeting specific protein-protein binding sites, such as the PB1-PA interaction, offers a novel approach for developing antiviral compounds.
- This strategy holds potential for combating influenza A virus and potentially other viral infections.
Related Concept Videos
Inhibitors Of Virion Release
Inhibitors of Viral Protein Synthesis
Leaky Scanning
Influenza
Inhibitors of Virion Maturation and Assembly
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

